OnQ Prostate, case study for the assessment and detection of prostate cancer
Dr. Schwazrtzberg uses OnQ Prostate to assess prostate cancer. He evaluates the case using T2, DWI, and ADC, then reviews an RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI increases conspicuity and how, in this case, it informs his designation of the PI-RADS number.
Join Dr. Schwartzberg and Dr. White on Dec. 3rd
We will review and discuss the benefits of OnQ Prostate for the detection of clinically significant prostate cancer using an advanced diffusion MRI technique called Restriction Spectrum Imaging (RSI). Dr. Schwartzberg shares cases from his practice at Imaging Healthcare Specialists in San Diego, California, where the use of OnQ Prostate has resulted in better, more accurate PI-RADS scoring than with conventional DWI/ ADC.
RSNA AI Theater Presentation
Dr. Bash uses NeuroQuant in the assessment of Alzheimer’s disease and reviews the features and benefits of LesionQuant and discusses the lesion detection threshold settings that enable each site to configure the minimum lesion size and the sensitivity within the infratentorial, leukocortical, periventricular, and white matter regions. She reviews lesion counts and volumetrics, as well as several overlay series that inform her diagnoses. Dr. Schwazrtzberg uses OnQ Prostate to assess prostate cancer. He evaluates the case using T2, DWI, and ADC, then reviews an RSI map and color fusion map provided by OnQ Prostate. He demonstrates how RSI increases conspicuity and how, in this case, it informs his designation of the PI-RADS number.
Contact Us
Would you prefer to add a date and time directly to a calendar? Click here to schedule a discovery meeting.
Schedule a Zoom Meeting
Select a date and time that fits your schedule
Schedule MeetingOr, submit your request through our contact form
